Results 171 to 180 of about 4,098 (181)

Sight‐threatening Graves’ orbitopathy: Twenty years’ experience of a multidisciplinary thyroid‐eye outpatient clinic

Clinical Endocrinology, 2019
Philippe Caron
exaly  

Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study

Journal of Endocrinological Investigation, 2020
Petros Perros, Luigi Bartalena, George J Kahaly   +2 more
exaly  

Late reactivation of thyroid orbitopathy

Clinical and Experimental Ophthalmology, 2004
Dinesh Selva
exaly  

Selenium and the Course of Mild Graves' Orbitopathy

New England Journal of Medicine, 2011
Claudio Marcocci, George J Kahaly, Luigi Bartalena   +2 more
exaly  

Current and Emerging Treatment Strategies for Graves’ Orbitopathy

Drugs, 2019
Natalia Genere, Marius N Stan
exaly  

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy

Frontiers in Endocrinology, 2020
George J Kahaly
exaly  

Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases

Endocrine Journal, 2011
exaly  

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy

Frontiers in Endocrinology, 2019
Federica Sileo, M Marin
exaly  

Orbital decompression in Graves’ orbitopathy: efficacy and safety

Internal Medicine Journal, 2005
exaly  

Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features

Graefe's Archive for Clinical and Experimental Ophthalmology, 2009
exaly